Amyris Inc
(NASDAQ: AMRS)| Exchange: | NASDAQ |
| Stock: | Amyris Inc |
| Industry: | Specialty Chemicals |
| Employees: | 380 |
| Amyris, Inc., formerly Amyris Biotechnologies, Inc. develops and provides renewable compounds for a variety of markets. As of December 31, 2012, the Company built and applied its industrial synthetic biology platform to provide alternatives to petroleum-sourced products used in specialty chemical and transportation fuel markets worldwide. The Company is focused on developing a range of products to address six markets: cosmetics, lubricants, flavors and fragrances, polymers, consumer products and transportation fuels. The Company’s call these No Compromise products because it design them to perform comparably to, or better than, available products. It genetically modifies micro organisms, primarily yeast, and uses them as living factories in established fermentation processes to convert plant-sourced sugars into thousands of molecules. The Company has two operating subsidiaries, Amyris Brasil Ltda. (formerly Amyris Brasil S.A.), or Amyris Brasil, and Amyris Fuels LLC, or Amyris Fuels. |
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.




